Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

• Status: Completed
• Trial end date: 2016-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Joseph D. Tobias
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• Patients previously admitted to the hospital presenting with traumatic brain injury (TBI)

• Patients who have undergone sedation after presenting with TBI

Exclusion Criteria:

• None